JPMorgan raised the firm’s price target on Tenet Healthcare (THC) to $230 from $200 and keeps an Overweight rating on the shares. The firm updated the company’s model.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Tenet Healthcare price target raised to $252 from $238 at Wells Fargo
- Tenet Healthcare Secures $1.9 Billion Credit Facility
- Tenet Healthcare Announces $2 Billion Debt Refinancing
- Tenet Healthcare price target raised to $240 from $225 at Truist
- Tenet Healthcare price target raised to $235 from $225 at Mizuho